Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lessons from Eprex for biogeneric firms.

× No keyword cloud information.

8 in total

1. Biosimilar growth hormone.

Authors: Paul Saenger
Journal: Indian J Pediatr Date: 2011-11-23 Impact factor: 1.967

Review 2. Through the looking glass: the protein science of biosimilars.

Authors: David Goldsmith; Martin Kuhlmann; Adrian Covic
Journal: Clin Exp Nephrol Date: 2007-09-28 Impact factor: 2.801

3. Feasibility of a multiplex flow cytometric bead immunoassay for detection of anti-epoetin alfa antibodies.

Authors: John Ferbas; John Thomas; John Hodgson; Amitabh Gaur; Nicole Casadevall; Steven J Swanson
Journal: Clin Vaccine Immunol Date: 2007-07-18

Review 4. Differentiating factors between erythropoiesis-stimulating agents: an update to selection for anaemia of chronic kidney disease.

Authors: Walter H Hörl
Journal: Drugs Date: 2013-02 Impact factor: 9.546

5. Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports.

Authors: Kevin Klein; Joep H G Scholl; Niels S Vermeer; André W Broekmans; Eugène P Van Puijenbroek; Marie L De Bruin; Pieter Stolk
Journal: Drug Saf Date: 2016-02 Impact factor: 5.606

6. The UK BIO-TRAC Study: A Cross-Sectional Study of Product and Batch Traceability for Biologics in Clinical Practice and Electronic Adverse Drug Reaction Reporting in the UK.

Authors: Kevin Klein; Lorna Hazell; Pieter Stolk; Saad Shakir
Journal: Drug Saf Date: 2020-03 Impact factor: 5.606

7. Current status of biosimilar growth hormone.

Authors: Paul Saenger
Journal: Int J Pediatr Endocrinol Date: 2009-09-29

8. Biosimilar therapeutics-what do we need to consider?

Authors: Huub Schellekens
Journal: NDT Plus Date: 2009-01

8 in total